Literature DB >> 10807596

Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney.

M Isono1, A Mogyorósi, D C Han, B B Hoffman, F N Ziyadeh.   

Abstract

Transforming growth factor-beta (TGF-beta) is important in the pathogenesis of diabetic nephropathy, but little is known about the regulation of the ligand-binding TGF-beta type II signaling receptor (TbetaIIR). There were significant increases in TbetaIIR protein and mRNA levels in kidney cortex after 1-6 wk of streptozotocin-induced diabetes. Mouse mesangial cells cultured in high glucose demonstrated significantly increased TbetaIIR protein and mRNA levels compared with normal glucose. This effect was independent of stimulation of TGF-beta bioactivity by high glucose. Consistent with transcriptional activation by high glucose, the half-life ( approximately 4 h) of TbetaIIR mRNA was not affected by glucose concentration. Moreover, mouse mesangial cells transiently transfected with reporter constructs containing the first 47- or 274-bp promoter fragments of TbetaIIR demonstrated significantly increased reporter activity in high glucose. Cells grown in high glucose demonstrated increased responsiveness to a relatively small dose of exogenous TGF-beta(1) (0.5 ng/ml): [(3)H]proline incorporation and alpha(1)(IV) collagen mRNA were significantly greater in cells cultured in high than in normal glucose. Hence, the expression of TbetaIIR is increased in the diabetic kidney and in mesangial cells cultured in high glucose, primarily because of stimulation of gene transcription. TbetaIIR upregulation by high ambient glucose may contribute to the increased sensitivity of mesangial cells to the profibrogenic action of TGF-beta(1).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807596     DOI: 10.1152/ajprenal.2000.278.5.F830

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  11 in total

Review 1.  A glimpse of various pathogenetic mechanisms of diabetic nephropathy.

Authors:  Yashpal S Kanwar; Lin Sun; Ping Xie; Fu-You Liu; Sheldon Chen
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

2.  Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.

Authors:  S W Hong; M Isono; S Chen; M C Iglesias-De La Cruz; D C Han; F N Ziyadeh
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

3.  Role of caveolae in high glucose and TGF-β₁ induced fibronectin production in rat mesangial cells.

Authors:  Yuantao Liu; Shengxia Lu; Yuchao Zhang; Xiangdong Wang; Feng Kong; Ye Liu; Li Peng; Yuqin Fu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Renal protection of in vivo administration of tempol in streptozotocin-induced diabetic rats.

Authors:  Jiajie Luan; Weiping Li; Jia Han; Wen Zhang; Huiling Gong; Rong Ma
Journal:  J Pharmacol Sci       Date:  2012-05-22       Impact factor: 3.337

5.  Essential role of TGF-beta signaling in glucose-induced cell hypertrophy.

Authors:  Liyu Wu; Rik Derynck
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

Review 6.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

7.  Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.

Authors:  Amy Jayne McKnight; David A Savage; Chris C Patterson; Denise Sadlier; A Peter Maxwell
Journal:  BMC Med Genet       Date:  2007-02-23       Impact factor: 2.103

8.  Phenotypic categorization of genetic skin diseases reveals new relations between phenotypes, genes and pathways.

Authors:  Ruslan I Sadreyev; Jamison D Feramisco; Hensin Tsao; Nick V Grishin
Journal:  Bioinformatics       Date:  2009-09-10       Impact factor: 6.937

Review 9.  Novel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathy.

Authors:  Montserrat Romero; Arantxa Ortega; Nuria Olea; María Isabel Arenas; Adriana Izquierdo; Jordi Bover; Pedro Esbrit; Ricardo J Bosch
Journal:  J Diabetes Res       Date:  2013-07-31       Impact factor: 4.011

10.  Inflammatory biomarkers in type 2 diabetic patients: effect of glycemic control and impact of LDL subfraction phenotype.

Authors:  Irene Vinagre; José Luis Sánchez-Quesada; Juan Sánchez-Hernández; David Santos; Jordi Ordoñez-Llanos; Alberto De Leiva; Antonio Pérez
Journal:  Cardiovasc Diabetol       Date:  2014-02-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.